Chengtie Wu
Editorial Board, Advanced Orthopaedics
Biomaterials and Tissue Engineering Research Center, Shanghal institute of Ceramics, chinese Academy of Sciences，Shanghai, China
Biomaterials and Tissue Engineering Research Center, Shanghal institute of Ceramics, chinese Academy of Sciences，Shanghai, China
Research Direction: New inorganic bioactive materials for complex tissue regeneration and repair and tissue engineering; Treatment of major diseases - multi-functional bioactive materials for tissue/organ regeneration and repair; Digital intelligent manufacturing of biological materials and bioprinting for tissue/organ regeneration.
Achievements: Chengtie Wu is currently a researcher and doctoral supervisor of Shanghai Institute of Silicate, Chinese Academy of Sciences, and Vice President of Shanghai Branch of Chinese Academy of Sciences.Awarded the National Science Fund for Outstanding Young People in August 2022, the National High-level Leaders Plan in March 2019, the Young and Middle-aged Leading Talents of the Ministry of Science and Technology in June 2018, the Chief of the Key Research and Development Plan of the Ministry of Science and Technology in August 2018, the National High-level Talents Plan in August 2012, the High-level Talents Plan of the Chinese Academy of Sciences in October 2012,In June 2015, he was selected as Shanghai Excellent Academic leader.Develop silicon-based bioactive ceramic system, propose and realize 3D printed structure biomimetic bioceramics for complex tissue regeneration and repair; First proposed the academic idea of "tissue repair and tumor therapy" bifunctional bioactive materials, and realized the organic combination of "tissue engineering" and "tumor therapy";It takes the lead in exploring silicon-based biomaterials for multicellular 3D printing in the world and opens up new research directions in this field.More than 300 SCI papers have been published in journals such as Advanced Materials, Materials Today, Science Advances and Biomaterials, with an h index of 88.Selected by Elsevier as China's most Cited Scholar for 8 consecutive years from 2015 to 2022;He edited a CRC English monograph and participated in writing 11 English monograph chapters.He has applied for 72 patents, of which 43 Chinese patents and 2 American patents have been authorized, and 25 have been transferred to enterprises.He is currently Associate editor of the academic journals "Applied Materials Today", "Microstructures" and "Journal of Inorganic Materials", "Acta Biomaterialia" and "Bioactive"Academic posts include editorial board member of "Materials", director of Chinese Society of Biomaterials, Deputy director of Bioceramics Branch of Chinese Society of Biomaterials, and Director of Science Popularization Committee of Chinese Society of Biomaterials.